BD gram-negative identification and drug susceptibility panel
Taiwan·Risk Class 2·BECTON DICKINSON AND COMPANY·Registered Jun 20, 2023 – Jun 20, 2028Active- Analysis ID
- e11b46d2969aafb53c9c21bc4ea4122b
- Customs Code
- DHA05603619302
- Manufacturer
- BECTON DICKINSON AND COMPANY
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- This product is a selective antimicrobial used for rapid identification and drug tolerance testing of most human sources of gram-negative aerobic bacteria and facultative anaerobic bacteria, and must be used with Phoenix automatic microbial system instrument.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1645 Automatic Antibiotic Sensitivity Test System for Short Incubation Period
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Jun 20, 2023
- Expiry Date
- Jun 20, 2028
Top companies providing products similar to "BD gram-negative identification and drug susceptibility panel"
Recently registered similar products
Access comprehensive regulatory information for BD gram-negative identification and drug susceptibility panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e11b46d2969aafb53c9c21bc4ea4122b and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including BECTON, DICKINSON AND COMPANY, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.